Roche Sales Decline More Than Expected As COVID Products Slide

Roche Sales Decline More Than Expected As COVID Products Slide

By Ludwig Burger (Reuters) -Roche’s quarterly sales declined 6% as a slump in COVID-19 treatments and diagnostic testing outweighed gains from haemophilia treatment Hemlibra and multiple sclerosis drug Ocrevus. Third-quarter revenue slipped to 14.74 billion Swiss francs ($14.84 billion), below market expectations of about 15.5 billion francs. “The third quarter of 2022 was particularly challenging…

Read More
Goldman To Merge Investment Banking, Trading As Marcus Takes Backseat

Goldman To Merge Investment Banking, Trading As Marcus Takes Backseat

By Saeed Azhar and Lananh Nguyen NEW YORK (Reuters) – Goldman Sachs Group Inc is expected to announce a major reorganization of its business lines on Tuesday, combining its trading and investment-banking divisions while likely sidelining its loss-making consumer unit. Observers are questioning the rationale of the expected move, but say it could streamline the…

Read More